Roche's Avastin Approved For Colon Cancer Treatment By FDA

The U.S. Food and Drug Administration (FDA) has approved use of Roche's Avastin for patients with colorectal cancer that has gotten worse despite treatment with the medication. This new approval will permit patients who were already treated once with Avastin plus chemotherapy to be treated again with Avastin in combination with a different chemotherapy regimen. Hal Barron, MD, Roche's Chief Medical Officer and Head of Global Product Development said: "The majority of people diagnosed with metastatic colorectal cancer receive Avastin plus chemotherapy as their initial treatment...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Colorectal Cancer Source Type: news